Patient Factors Associated With Reimplantation After Girdlestone Resection Arthroplasty for Treatment of Periprosthetic Joint Infections of the Hip.

IF 2 Q2 ORTHOPEDICS
Jeffrey Okewunmi, Avanish Yendluri, John K Cordero, Nicole Zubizarreta, Darwin Chen, Calin S Moucha, Jashvant Poeran, Brett L Hayden
{"title":"Patient Factors Associated With Reimplantation After Girdlestone Resection Arthroplasty for Treatment of Periprosthetic Joint Infections of the Hip.","authors":"Jeffrey Okewunmi, Avanish Yendluri, John K Cordero, Nicole Zubizarreta, Darwin Chen, Calin S Moucha, Jashvant Poeran, Brett L Hayden","doi":"10.5435/JAAOSGlobal-D-24-00005","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>For patients unsuitable for prosthesis reimplantation or temporary spacer placement, Girdlestone resection arthroplasty (GRA) is a suitable option to eliminate infection. Using a large-scale database, this study aims to determine factors associated with reimplantation.</p><p><strong>Methods: </strong>This study included patients who underwent GRA and subsequent total hip arthroplasty (2012 to 2015 Medicare Limited Data Set with ≥5-year follow-up). A mixed-effects model measured associations between patient characteristics and reimplantation. Odds ratios (OR) with 95% confidence intervals (CI) were reported.</p><p><strong>Results: </strong>Among 2,772 GRA cases, 2,025 (73.1%) were reimplanted (median time to reimplantation 3.0 months). In multivariable analysis, patient factors associated with reduced odds of reimplantation were increased age (OR 0.96; CI, 0.94 to 0.97; P < 0.0001), Black race (OR, 0.58; CI, 0.37 to 0.90; P = 0.0149), obesity (OR, 0.74; CI, 0.58 to 0.94; P = 0.0150), and increased Deyo-Charlson comorbidities (1 comorbidity: OR, 0.78; CI, 0.61 to 0.99; P = 0.0453; two comorbidities: OR, 0.53; CI, 0.39 to 0.71; P < 0.0001; ≥3 comorbidities: OR, 0.69; CI, 0.49 to 0.95; P = 0.0244). Male (versus female) patients, however, had increased odds of reimplantation (OR, 1.64; CI, 1.32 to 2.02; P < 0.0001).</p><p><strong>Discussion: </strong>Age, race, and comorbidities influence the likelihood of reimplantation after GRA. Owing to variability in patients who undergo additional surgery, additional studies should be conducted to determine the rationale of patient selection.</p>","PeriodicalId":45062,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews","volume":"8 9","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11404882/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5435/JAAOSGlobal-D-24-00005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: For patients unsuitable for prosthesis reimplantation or temporary spacer placement, Girdlestone resection arthroplasty (GRA) is a suitable option to eliminate infection. Using a large-scale database, this study aims to determine factors associated with reimplantation.

Methods: This study included patients who underwent GRA and subsequent total hip arthroplasty (2012 to 2015 Medicare Limited Data Set with ≥5-year follow-up). A mixed-effects model measured associations between patient characteristics and reimplantation. Odds ratios (OR) with 95% confidence intervals (CI) were reported.

Results: Among 2,772 GRA cases, 2,025 (73.1%) were reimplanted (median time to reimplantation 3.0 months). In multivariable analysis, patient factors associated with reduced odds of reimplantation were increased age (OR 0.96; CI, 0.94 to 0.97; P < 0.0001), Black race (OR, 0.58; CI, 0.37 to 0.90; P = 0.0149), obesity (OR, 0.74; CI, 0.58 to 0.94; P = 0.0150), and increased Deyo-Charlson comorbidities (1 comorbidity: OR, 0.78; CI, 0.61 to 0.99; P = 0.0453; two comorbidities: OR, 0.53; CI, 0.39 to 0.71; P < 0.0001; ≥3 comorbidities: OR, 0.69; CI, 0.49 to 0.95; P = 0.0244). Male (versus female) patients, however, had increased odds of reimplantation (OR, 1.64; CI, 1.32 to 2.02; P < 0.0001).

Discussion: Age, race, and comorbidities influence the likelihood of reimplantation after GRA. Owing to variability in patients who undergo additional surgery, additional studies should be conducted to determine the rationale of patient selection.

治疗髋关节假体周围感染的 Girdlestone 切除关节成形术后再植的患者相关因素。
简介:对于不适合假体再植或临时垫片植入的患者,Girdlestone切除关节成形术(GRA)是消除感染的合适选择。本研究利用大规模数据库,旨在确定与再植相关的因素:本研究纳入了接受 GRA 和后续全髋关节置换术的患者(2012 年至 2015 年医疗保险有限数据集,随访时间≥5 年)。混合效应模型测量了患者特征与再植之间的关系。结果显示:在2772例GRA病例中,有2772人接受了再植手术,占比比(OR)为95%,置信区间(CI)为95%:在 2,772 例 GRA 患者中,2,025 例(73.1%)进行了再植(再植中位时间为 3.0 个月)。在多变量分析中,与再植几率降低相关的患者因素有:年龄增加(OR,0.96;CI,0.94 至 0.97;P < 0.0001)、黑人种族(OR,0.58;CI,0.37 至 0.90;P = 0.0149)、肥胖(OR,0.74;CI,0.58 至 0.94;P = 0.0150)和 Deyo-Charlson 合并症增加(1 种合并症:OR,0.78;CI,0.94;P = 0.0001):OR,0.78;CI,0.61 至 0.99;P = 0.0453;两个合并症:OR,0.53;CI,0.39 至 0.71;P <0.0001;≥3 个合并症:OR,0.69;CI,0.49 至 0.95;P = 0.0244)。然而,男性(相对于女性)患者再次植入的几率增加(OR,1.64;CI,1.32 至 2.02;P <0.0001):讨论:年龄、种族和合并症会影响 GRA 后再植的可能性。讨论:年龄、种族和合并症会影响 GRA 后再植的可能性。由于接受额外手术的患者存在差异,因此应开展更多研究以确定选择患者的理由。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.60
自引率
6.70%
发文量
282
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信